Locally Advanced Pancreatic Cancer Market Analysis Through 2030 Focusing On Demand Trends And Growth Drivers
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Market Value Trend Is Expected For The Locally Advanced Pancreatic Cancer Market From 2026 To 2030?
The market for locally advanced pancreatic cancer has seen significant expansion in recent years. Projections indicate it will expand from $1.05 billion in 2025 to reach $1.16 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 10.5%. Historically, this expansion can be linked to factors such as the late-stage identification of pancreatic cancer, restricted surgical options for locally advanced instances, the traditional dependence on gemcitabine-based chemotherapy, low overall patient survival rates, and the increase in hospital-based oncology services.
The market size for locally advanced pancreatic cancer is projected to experience substantial expansion in the coming years. This market is predicted to reach $1.71 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. Several factors will drive this growth during the forecast period, including the broadening of combination therapy protocols, the increasing uptake of SBRT, heightened investment in pancreatic cancer research, a rising emphasis on personalized oncology care, and the growing accessibility of advanced treatment centers. Key trends anticipated within the forecast period encompass a greater utilization of combination chemotherapy regimens, the expanding adoption of neoadjuvant treatment strategies, a heightened focus on tumor downstaging to improve surgical eligibility, the broadened application of radiation therapy for localized disease control, and an increasing emphasis on multidisciplinary treatment planning.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21214&type=smp
What Key Growth Drivers Are Influencing The Locally Advanced Pancreatic Cancer Market?
The rising use of tobacco is expected to propel the growth of the locally advanced pancreatic cancer markets in the future. Tobacco, a plant whose leaves are utilized in items like cigarettes and cigars, contains nicotine, which is addictive and associated with serious health conditions such as cancer and heart disease. The increase in tobacco consumption is influenced by factors including easy accessibility, affordability, tobacco marketing efforts, social acceptance in certain areas, and stress-related smoking. Tobacco use is a significant risk factor for the development of locally advanced pancreatic cancer, as it contributes to a higher incidence of pancreatic malignancies. For example, in October 2024, a study from the European Respiratory Society’s (ERS), a Switzerland-based non-profit organization, examining smoking trends among young people revealed a notable surge in smoking rates, with 22.5% of respondents smoking in 2022 compared to 40.1% in 2024. Therefore, the increased tobacco consumption is driving the expansion of the locally advanced pancreatic cancer market.
What Are The Core Segment Classifications In The Locally Advanced Pancreatic Cancer Market?
The locally advanced pancreatic cancer market covered in this report is segmented –
1) By Therapy: Chemotherapy, Radiation Therapy
2) By Route Of Administration: Oral, Injectables, Other Routes Of Administrations
3) By End-User: Hospital, Specialty Clinics, Research Institutions, Other End-Users
Subsegments:
1) By Chemotherapy: Gemcitabine-based Chemotherapy, FOLFIRINOX Chemotherapy
2) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy (SBRT)
Which Trends Are Affecting The Locally Advanced Pancreatic Cancer Market Framework?
Companies operating in the locally advanced pancreatic cancer market are primarily focused on developing novel products, such as orphan drugs, to enhance treatment options, improve patient outcomes, and address the unmet medical needs associated with this aggressive disease. Orphan drugs are specifically designed to treat rare diseases affecting a small demographic and are incentivized by regulatory authorities with benefits like tax reductions and market exclusivity to encourage their development. For instance, in January 2025, Actuate Therapeutics Inc., a US-based biopharmaceutical company, announced that its Elraglusib, a new GSK-3β inhibitor, received Orphan Drug Designation from both the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) for treating pancreatic ductal adenocarcinoma (PDAC) (a potential types of locally advanced pancreatic cancer). This recognition underscores its potential to fill a critical gap in treating this severe cancer, particularly following promising Phase 2 trial results demonstrating significant clinical improvements and anti-tumor effects in metastatic PDAC patients.
Which Companies Are Influencing The Locally Advanced Pancreatic Cancer Market?
Major companies operating in the locally advanced pancreatic cancer market are Pfizer Inc, F Hoffmann La Roche Ltd, Merck and Co Inc, Bristol Myers Squibb Company, AstraZeneca plc, AbbVie Inc, Novartis AG, GSK plc, Bayer AG, Eli Lilly and Company, Ipsen, Takeda Pharmaceutical Company Limited, Amgen Inc, Sanofi, Servier, NovoCure Limited, Halozyme Therapeutics, Clovis Oncology, Astellas Pharma, BeiGene
Access The Complete Locally Advanced Pancreatic Cancer Market Report:
Which Region Holds The Largest Share In The Locally Advanced Pancreatic Cancer Market?
North America was the largest region in the locally advanced pancreatic cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the locally advanced pancreatic cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Locally Advanced Pancreatic Cancer Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=21214&type=smp
Browse Through More Reports Similar to the Global Locally Advanced Pancreatic Cancer Market 2026, By The Business Research Company
Invasive Ductal Carcinoma Therapeutics Global Market Report 2026
Pancreatic Cancer Drugs Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report
Gastroesophageal Junction Adenocarcinoma Therapeutics Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
